Clinical Trials Browser

Efficacy and Safety of Short-course Radiotherapy in Total Neoadjuvant Therapy Combined With Enlonstobart for pMMR Locally Advanced Rectal Cancer

NCT07397442 2026-02-11

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

Phase 2 Not yet recruiting

19 enrolled

Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Phase 2 Not yet recruiting

38 enrolled

Gastrointestinal

Pancreatic Cancer Liver Metastases

NCT07259473 2026-01-07

Pre-CATALIS

Phase 2 Not yet recruiting

15 enrolled

Turcot syndrome

NCT07293247 2025-12-22

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Phase 2 Not yet recruiting

164 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07297030 2025-12-22

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

Phase 2 Not yet recruiting

37 enrolled

Gastrointestinal

Rectal Neoplasms

NCT07258147 2025-12-02

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

Phase 2 Not yet recruiting

30 enrolled

Thoracic

Lung Neoplasms

NCT07254858 2025-11-28

CISN-L

Phase 2 Not yet recruiting

302 enrolled

Breast

Breast Neoplasms

NCT07231575 2025-11-18

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

Phase 2 Not yet recruiting

39 enrolled

Thoracic

Neoadjuvant Immunotherapy

NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

Phase 2 Not yet recruiting

40 enrolled

Gastrointestinal

Hyperthermia, Gastrointestinal Neoplasms

NCT06908668 2025-04-03

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Phase 2 Not yet recruiting

170 enrolled

Breast

HER2-Negative Locally Advanced Breast Cancer

NCT06691594 2025-02-20

Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy

Phase 2 Not yet recruiting

20 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06599827 2024-09-19

iMHRT-LARC

Phase 2 Not yet recruiting

54 enrolled

Gastrointestinal

Rectal Neoplasms

NCT06009029 2023-08-24

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

Phase 2 Not yet recruiting

96 enrolled

Gastrointestinal

Locally Advanced Pancreatic Cancer

NCT05794750 2023-04-06

AK104-IIT-13

Phase 2 Not yet recruiting

50 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05791136 2023-03-30

TREE

Phase 2 Not yet recruiting

30 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05359393 2022-11-14

Miracle-1

Phase 2 Not yet recruiting

52 enrolled

Gastrointestinal

Advanced Rectal Cancer

Clinical Trials

Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

Pre-CATALIS

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

SIB-RT Combined With CAPOX and PD-1 for High-Risk Rectal Cancer

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

CISN-L

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy

iMHRT-LARC

SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)

AK104-IIT-13

TREE

Miracle-1